Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02930850 · ClinicalTrials.gov registry record · NA
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
A NA study of Healthy and Anemia, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 447
- Enrollment target
- 7
- Study locations
NCT02930850: Completed NA study of Healthy and Anemia, sponsored by Masimo Corporation.
NCT02930850 is a NA study of Healthy and Anemia that has completed, run by Masimo Corporation. The registered enrollment target is 447 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (31% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02930850, a NA study of Healthy and Anemia, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 447 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer.
Primary Outcome
Accuracy willl be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.
Conditions Studied
Interventions
- DEVICE Rad-67 Pulse oximeter
Study Locations (7)
California
- Site 4 - Burbank
- Site 5 - Burbank
- Site 2 - Irvine
- Site 7 - Lake Forest
- Site 3 - National City
- Site 6 - Torrance
North Carolina
- Site 1 - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 447 participants |
| Start Date | 2016-09 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT02930850 record still lists
NCT02930850 is an interventional study that assigns participants to a tested intervention. The registered 447 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (31% lower).
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Rad-67 Pulse oximeter is the first listed.
NCT02930850 lists 7 locations in 2 states (California, North Carolina).
Frequently Asked Questions
What is clinical trial NCT02930850 about?
NCT02930850 is a clinical study titled "Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation". The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer.
What is the current status of trial NCT02930850?
This trial is currently completed. It is a NA study. The enrollment target is 447 participants. The study started on 2016-09. Estimated completion is 2016-10.
What conditions does trial NCT02930850 study?
This clinical trial studies the following conditions: Healthy, Anemia, Pediatric ALL.
What interventions are being tested in trial NCT02930850?
The interventions under investigation include: Rad-67 Pulse oximeter (DEVICE).
Who is sponsoring clinical trial NCT02930850?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02930850 being conducted?
This trial has 7 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02930850's enrollment target sits among peer trials
447 56th of 1090 higher than 1,035 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT06702449 · 448 participants · Phase 1
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- NCT07125053 · 448 participants · NA
COPD Resources, Education, and Activity Designed for You Study
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia